Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Immunother. 2010 Nov-Dec;33(9):965–974. doi: 10.1097/CJI.0b013e3181fb045d

Figure 4. Melanoma cell lines produce CXCL9, CXCL10, and CXCL11 in response to IFN-α or IFN-γ treatment.

Figure 4

Melanoma cell lines were cultured in 24 well plates at 1×106 cells per mL, either without or with 1×105 IU of IFN–α or IFN–γ for 24 hours. The supernatants were assayed in triplicate by ELISA for CXCL9 (A), CXCL10 (B), and CXCL11 (C). Data are means ± standard deviation of ELISA results from one of three independent assays.